Mark Hopper Jonathan's Insider Trades & SAST Disclosures
Mark Hopper Jonathan's most recent trade in Vericel Corp was a trade of 10,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Mark Hopper Jonathan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 10,000 | 28,750 | - | - | Stock Option (Right to Buy) | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.00 per share. | 03 Mar 2025 | 10,000 | 76,101 (0%) | 0% | 18 | 180,000 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 49.53 per share. | 03 Mar 2025 | 10,000 | 66,101 (0%) | 0% | 49.5 | 495,300 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 1,500 | 9,000 | - | - | Restricted Stock Unit | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 1,500 | 10,500 | - | - | Restricted Stock Unit | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 1,500 | 66,737 (0%) | 0% | 0 | Common Stock | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 1,500 | 65,237 (0%) | 0% | - | Common Stock | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.33 per share. | 24 Feb 2025 | 636 | 66,101 (0%) | 0% | 52.3 | 33,282 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 14,000 | 14,000 | - | - | Restricted Stock Unit | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 3,000 | 6,000 | - | - | Restricted Stock Unit | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 3,000 | 61,500 (0%) | 0% | - | Common Stock | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 2,325 | 2,325 | - | - | Restricted Stock Unit | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 2,325 | 63,825 (0%) | 0% | 0 | Common Stock | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 1,750 | 64,590 (0%) | 0% | 0 | Common Stock | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 1,750 | 0 | - | - | Restricted Stock Unit | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.28 per share. | 18 Feb 2025 | 985 | 62,840 (0%) | 0% | 57.3 | 56,421 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.78 per share. | 18 Feb 2025 | 853 | 63,737 (0%) | 0% | 57.8 | 49,286 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 34.04 per share. | 31 Dec 2024 | 129 | 58,500 (0%) | 0% | 34.0 | 4,391 | Common Stock |
| Vericel Corp | Hopper Jonathan Mark | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.66 per share. | 02 Dec 2024 | 10,000 | 68,371 (0%) | 0% | 16.7 | 166,600 | Common Stock |
| Vericel Corp | Mark Jonathan Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 10,000 | 6,000 | - | - | Stock Option (Right to Buy) | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 58.72 per share. | 02 Dec 2024 | 10,000 | 58,371 (0%) | 0% | 58.7 | 587,200 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.95 per share. | 03 Sep 2024 | 10,000 | 68,229 (0%) | 0% | 11.0 | 109,500 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2024 | 10,000 | 12,604 | - | - | Stock Option (Right to Buy) | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 49.83 per share. | 03 Sep 2024 | 10,000 | 58,229 (0%) | 0% | 49.8 | 498,300 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 10,000 | 22,604 | - | - | Stock Option (Right to Buy) | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 49.99 per share. | 20 May 2024 | 10,000 | 58,116 (0%) | 0% | 50.0 | 499,900 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.95 per share. | 20 May 2024 | 10,000 | 68,116 (0%) | 0% | 11.0 | 109,500 | Common Stock |
| Vericel Corp | Mark Jonathan Hopper | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Vericel Corp | Mark Hopper Jonathan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 12,000 | 12,000 | - | - | Restricted Stock Unit | |
| Vericel Corp | Jonathan Hopper Mark | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 3,000 | 56,984 (0%) | 0% | 0 | Common Stock | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 3,000 | 9,000 | - | - | Restricted Stock Unit | |
| Vericel Corp | Jonathan Hopper Mark | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 2,325 | 57,930 (0%) | 0% | 0 | Common Stock | |
| Vericel Corp | Jonathan Hopper Mark | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 2,325 | 4,650 | - | - | Restricted Stock Unit | |
| Vericel Corp | Hopper Mark Jonathan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 1,750 | 58,695 (0%) | 0% | 0 | Common Stock | |
| Vericel Corp | Jonathan Hopper Mark | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 1,750 | 1,750 | - | - | Restricted Stock Unit | |
| Vericel Corp | Jonathan Hopper Mark | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.50 per share. | 20 Feb 2024 | 1,379 | 55,605 (0%) | 0% | 49.5 | 68,261 | Common Stock |
| Vericel Corp | Mark Hopper Jonathan | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.50 per share. | 20 Feb 2024 | 985 | 56,945 (0%) | 0% | 49.5 | 48,758 | Common Stock |
| Vericel Corp | Mark Hopper Jonathan | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.50 per share. | 20 Feb 2024 | 742 | 57,953 (0%) | 0% | 49.5 | 36,729 | Common Stock |
| Vericel Corp | Mark Jonathan Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 1,625 | 0 | - | - | Restricted Stock Unit | |
| Vericel Corp | Mark Hopper Jonathan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 1,625 | 54,759 (0%) | 0% | 0 | Common Stock | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.42 per share. | 12 Feb 2024 | 775 | 53,984 (0%) | 0% | 47.4 | 36,751 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 28,125 | 28,125 | - | - | Stock Option (Right to Buy) | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 12,000 | 12,000 | - | - | Restricted Stock Unit | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 2,325 | 6,975 | - | - | Restricted Stock Unit | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 2,325 | 52,522 (0%) | 0% | 0 | Common Stock | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 1,875 | 1,875 | - | - | Stock Option (Right to Buy) | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 1,750 | 53,164 (0%) | 0% | 0 | Common Stock | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 1,750 | 3,500 | - | - | Restricted Stock Unit | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.82 per share. | 17 Feb 2023 | 1,108 | 51,414 (0%) | 0% | 29.8 | 33,041 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.82 per share. | 17 Feb 2023 | 752 | 52,412 (0%) | 0% | 29.8 | 22,425 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 1,625 | 51,037 (0%) | 0% | 0 | Common Stock | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 1,625 | 1,625 | - | - | Restricted Stock Unit | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.30 per share. | 11 Feb 2023 | 840 | 50,197 (0%) | 0% | 29.3 | 24,612 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 650 | 0 | - | - | Restricted Stock Unit | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 650 | 49,722 (0%) | 0% | 0 | Common Stock | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.60 per share. | 06 Feb 2023 | 310 | 49,412 (0%) | 0% | 30.6 | 9,486 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.00 per share. | 01 Mar 2022 | 10,000 | 55,914 (0%) | 0% | 18 | 180,000 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.95 per share. | 01 Mar 2022 | 10,000 | 55,914 (0%) | 0% | 11.0 | 109,500 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 41.41 per share. | 01 Mar 2022 | 10,000 | 45,914 (0%) | 0% | 41.4 | 414,060 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 10,000 | 37,604 | - | - | Stock Option (right to buy) | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 10,000 | 38,750 | - | - | Stock Option (right to buy) | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 41.46 per share. | 01 Mar 2022 | 6,738 | 49,176 (0%) | 0% | 41.5 | 279,371 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 51,385 | 51,385 | - | - | Stock Option (right to buy) | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 9,300 | 9,300 | - | - | Restricted Stock Unit | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 2,865 | 2,865 | - | - | Stock Option (right to buy) | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2022 | 1,750 | 46,644 (0%) | 0% | 0 | Common Stock | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2022 | 1,750 | 5,250 | - | - | Restricted Stock Unit | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.90 per share. | 18 Feb 2022 | 730 | 45,914 (0%) | 0% | 34.9 | 25,477 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 1,625 | 45,669 (0%) | 0% | 0 | Common Stock | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 1,625 | 3,250 | - | - | Restricted Stock Unit | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.26 per share. | 11 Feb 2022 | 775 | 44,894 (0%) | 0% | 35.3 | 27,327 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2022 | 650 | 650 | - | - | Restricted Stock Unit | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2022 | 650 | 44,354 (0%) | 0% | 0 | Common Stock | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.91 per share. | 06 Feb 2022 | 310 | 44,044 (0%) | 0% | 33.9 | 10,512 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2021 | 10,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.66 per share. | 20 Dec 2021 | 10,000 | 49,428 (0%) | 0% | 16.7 | 166,600 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2021 | 9,000 | 47,604 | - | - | Stock Option (right to buy) | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 40.14 per share. | 20 Dec 2021 | 9,000 | 39,428 (0%) | 0% | 40.1 | 361,238 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.95 per share. | 20 Dec 2021 | 9,000 | 48,428 (0%) | 0% | 11.0 | 98,550 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 40.08 per share. | 20 Dec 2021 | 5,881 | 43,547 (0%) | 0% | 40.1 | 235,692 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.95 per share. | 20 Dec 2021 | 1,000 | 40,428 (0%) | 0% | 11.0 | 10,950 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2021 | 1,000 | 56,604 | - | - | Stock Option (right to buy) | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 20 Dec 2021 | 1,000 | 39,428 (0%) | 0% | 40 | 40,000 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.95 per share. | 30 Jun 2021 | 694 | 39,453 (0%) | 0% | 10.9 | 7,599 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2021 | 694 | 57,604 | - | - | Stock Option (right to buy) | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 57.14 per share. | 30 Jun 2021 | 134 | 39,319 (0%) | 0% | 57.1 | 7,657 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.95 per share. | 30 Mar 2021 | 20,000 | 49,584 (0%) | 0% | 11.0 | 219,000 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2021 | 20,000 | 66,736 | - | - | Stock Option (right to buy) | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 51.84 per share. | 30 Mar 2021 | 11,104 | 38,480 (0%) | 0% | 51.8 | 575,645 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.95 per share. | 30 Mar 2021 | 8,438 | 31,404 (0%) | 0% | 10.9 | 92,396 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2021 | 8,438 | 58,298 | - | - | Stock Option (right to buy) | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2021 | 5,000 | 86,736 | - | - | Stock Option (right to buy) | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.95 per share. | 30 Mar 2021 | 5,000 | 27,966 (0%) | 0% | 11.0 | 54,750 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 50.56 per share. | 30 Mar 2021 | 5,000 | 22,966 (0%) | 0% | 50.6 | 252,805 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 51.00 per share. | 30 Mar 2021 | 1,820 | 29,584 (0%) | 0% | 51 | 92,820 | Common Stock |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 57,177 | 57,177 | - | - | Stock Option (right to buy) | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 7,000 | 7,000 | - | - | Restricted Stock Unit | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 2,823 | 2,823 | - | - | Stock Option (right to buy) | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 1,625 | 25,371 (0%) | 0% | 0 | Common Stock | |
| Vericel Corp | Jonathan Mark Hopper | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 1,625 | 4,875 | - | - | Restricted Stock Unit |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges